Supporter and Exhibitor Information

Summit of the Americas on Immunotherapies for Hematologic Malignancies, Third Annual

We would be pleased if you would join us as an exhibitor at the Miami Cancer Institute Summit of the Americas on Immunotherapies for Hematologic Malignancies, Third Annual  on Friday-Saturday, April 22-23, 2022 at The Ritz-Carlton Coconut Grove.

Given the increasing frequency of hematologic malignancies, complexities of treatments with novel agents and particularly with immunotherapeutic approaches, there is a need to provide an opportunity for oncologists, hematologists and oncology nurses to engage in thoughtful discussions with experts in these fields. In addition, there is emerging data about the biology of these malignancies impacting optimal management of patients with these disorders. Clinical decision making and management, therefore, have become more complex.

This one-and-a-half-day symposium has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of leukemia, lymphoma, multiple myeloma and stem cell transplantation by novel immunotherapies and treatment combinations. Updates on evolving immunologically and molecular-based system therapies will be profiled and discussed.

Networking Opportunities - Luncheon Supporter - Wi-Fi and A/V Supporter

When you participate in this CME/CE event, you will network one-on-one with physicians, leaders and healthcare providers affiliated with Miami Cancer Institute and, the Greater South Florida medical community, as well as from around the United States and abroad.

As a Gold Level Supporter, your company will also be recognized for one year as a Corporate Philanthropy Partners program member of Baptist Health. Distinct and significant recognition will be provided at the symposium, as well as at the luncheon, in the conference hall and on the website in advance of the symposium. Details are on the following pages.

Symposium Objectives

  • Summarize the evolving therapeutic strategies in the treatment of hematologic malignancies
  • Provide an update of new molecular and immunological treatments being developed for these diseases.
  • Discuss the rationale for new targeted diagnostic and therapeutic strategies for lymphoma, myeloma and leukemia.
  • Review the role and timing of hematopoietic cell transplantation and potential combinations of immunotherapeutic treatment options.

Target Audience

This educational program is directed toward hematologists, oncologists, pathologists, radiation oncologists, palliative care staff, oncology and hematology nurses, and other allied health care members interested in the treatment of patients with hematologic malignancies.

Next Steps

Due Tuesday, March 22

Review the exhibitor prospectus linked below to select a support level. 

Exhibitor Prospectus

Confirm your intent to reserve an exhibit. To reserve your exhibit, please return a signed copy of the Exhibitor Registration Form linked below. Baptist Health CME reserves the right to determine a company’s eligibility to exhibit, based on the company’s products’ relevance to the practice of immunotherapy.

Exhibitor Application Form

If you have any questions, please contact Anna Busto.

Due Tuesday, March 22
Provide payment or proof of payment in process.